Brucellosis-induced autoimmune hemolytic anemia treated with rituximab

Annals of Pharmacotherapy

Volumn 44, Issue 10, 2010, Pages 1677-1680

  Bourantas, Lambros K ^a   Pappas, Georgios ^b   Kapsali, Eleni ^c   Gougopoulou, Dora ^a   Papamichail, Dimitrios ^a   Bourantas, Konstantinos L ^c  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b Institute of Continuing Medical Education of Ioannina   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Autoimmune hemolytic anemia; Brucellosis; Rituximab

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; DOXYCYCLINE; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE; PREDNISONE; RIFAMPICIN; RITUXIMAB;

ADD ON THERAPY; AGED; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BACKACHE; BILIRUBIN BLOOD LEVEL; BODY TEMPERATURE; BONE DEFECT; BONE SCINTISCANNING; BRUCELLA; BRUCELLOSIS; BRUCELLOSIS INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; COOMBS TEST; DISEASE SEVERITY; DRUG EFFICACY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; FEVER; GRANULOMATOSIS; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LIVER GRANULOMA; LIVER INJURY; NONHUMAN; PRIORITY JOURNAL; RETICULOCYTE COUNT; SEROLOGY; SPLENOMEGALY; TREATMENT RESPONSE;

AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BRUCELLOSIS; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOLOGIC FACTORS; PREDNISONE; TREATMENT FAILURE;

EID: 77957671706     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P249     Document Type: Article

References (31)

1. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005;352:2325-36.
2. Bourantas KL, Christou LG, Dalekos GN, Barbati K, Tsianos EV. A 54-year-old stockbreeder with ascites. Lancet 1997;349:994.
3. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006;6:91-9.
4. Colmenero JD, Reguera JM, Martos F, et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 1996;75:195-211.
5. Pappas G, Kitsanou M, Christou L, Tsianos E. Immune thrombocytopenia attributed to brucellosis, and other mechanisms of Brucella-induced thrombocytopenia. Am J Hematol 2004;75:139-41.
6. Altuntas F, Eser B, Sari I, Yildiz O, Cetin M, Unal A. Severe thrombotic microangiopathy associated with brucellosis: successful treatment with plasmapheresis. Clin Appl Thromb Hemost 2005;11:105-8.
7. Calvo Villas JM, Queizan Hernandez JA, Moreno Palomares FJ, Soto Guzman O. Microangiopathic hemolytic anemia associated with acute brucellosis. Med Clin (Barc) 1997;109:236.
8. Bouza E, Sánchez-Carrillo C, Hernangómez S, et al. Laboratory-acquired brucellosis: a Spanish national survey. J Hosp Infect 2005;61:80-3.
9. Pappas G, Panagopoulou P, Christou L, Akritidis N. Brucella as a biological weapon. Cell Mol Life Sci 2006;63:2229-36.
10. Ariza J, Bosilkovski M, Cascio A, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 2007;4:e317.
11. Sari I, Altuntas F, Hacioglu S, et al. A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis. Am J Hematol 2008;83:334-9.
12. Akritidis N, Tzivras M, Delladetsima I, Stefanaki S, Moutsopoulos HM, Pappas G. The liver in brucellosis. Glin Gastroenterol Hepatol 2007;5:1109-12.
13. Wehbe E, Moore TA. Cold agglutinin-associated hemolytic anemia due to brucellosis: first case report. Am J Hematol 2008;83:685-6.
14. Pamuk GE, Dogan Celik A, Uyanik MS. Brucellosis triggering hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency. Med Princ Pract 2009;18:329-31.
15. Music N, Hadzic E. Acute brucellosis associated with Coombs-positive autoimmune hemolytic anemia and disseminated intravascular coagulation (DIC). Med Glas 2009;6:265-8.
16. Jacob NR, Rodriguez CG, Binaghi MA, et al. Brucellosis complicating chronic non-infectious disorders: diagnostic and therapeutic dilemmas. J Med Microbiol 2008;57:1161-6.
17. Sari I, Kocyigit I, Altuntas F, Kaynar L, Eser B. An unusual case of acute brucellosis presenting with Coombs-positive autoimmune hemolytic anemia. Intern Med 2008;47:1043-5.
18. Garcia P, Yrivarren JL, Argumans C, Crosby E, Carrillo C, Gotuzzo E. Evaluation of the bone marrow in patients with brucellosis. Clinicopathological correlation. Enferm Infecc Microbiol Clin 1990;8:19-24.
19. Dilek I, Durmus A, Karahocagil MK, et al. Hematological complications in 787 cases of acute brucellosis in eastern Turkey. Turk J Med Sci 2008;38:421-4.
20. al-Eissa Y, al-Nasser M. Haematological manifestations of childhood brucellosis. Infection 1993;21:23-6.
21. Frutus F, Gato A, Gaspar G, Alcaraz M. Hemolysis secondary to acute brucellosis. Enferm Infecc Microbiol Clin 1991;9:259-60.
22. Girard M, Treppoz M, Mestrallet G, Martin F. Melitococcosis of the hemolytic anemia type. Lyon Med 1960;92:319-21.
23. Meggio B. Acute hemolytic anemia with hemoglobinuria during Brucella infection. Athena 1956;22:267-70.
24. Bieniecki T. Association of severe brucellosis with systemic hemolytic anemia. Pol Arch Med Wewn 1955;25:1143-51.
25. Sevinc A, Buyukberber N, Camci C, Buyukberber S, Karsligil T. Thrombocytopenia in brucellosis: case report and literature review. J Natl Med Assoc 2005;97:290-3.
26. Tsirka A, Markesinis I, Getsi V, Chaloulou S. Severe thrombocytopenic purpura due to brucellosis. Scand J Infect Dis 2002;34:535-6.
27. Bussone G, Ribeiro E, Dechartres A, et al. Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases. Am J Hematol 2009;84:153-7.
28. Peñalver FJ, Alvarez-Larrán A, Díez-Martin JL, et al. Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia. Ann Hematol 2010; in press. PMID 20526716
29. Palombi M, Niscola P, Trawinska MM, et al. Long-lasting remission induced by rituximab in two cases of refractory autoimmune haemolytic anaemia due to cold agglutinins (letter). Blood Transfus 2009;7:235-6.
30. Lechner K, Jäger U. How I treat autoimmune hemolytic anemias in adults. Blood 2010; in press. PMID 20548093
31. Mourtzoukou EG, Pappas G, Peppas G, Falagas ME. Vaccination of asplenic or hyposplenic adults. Br J Surg 2008;95:273-80.